Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CLPTthis companyClearPoint Neuro, Inc.	$9.15	-15.2×	13.82×	10.48×	-19.16×	-221.0%	61.4%	-65.4%	-69.1%	-91.1%	-27.6%	-6.3%	2.08×	-0.59×	-10.12×	5.91×	0.0%	2	-0.73	1	D+
AKBAAkebia Therapeutics, Inc.	$0.49	-77.4×	12.7×	1.75×	20.5×	-604.2%	83.3%	9.9%	-2.3%	-16.4%	9.3%	16.4%	6.63×	1.45×	0.97×	1.13×	0.0%	3	-5.78	1	D+
CTKBCytek Biosciences, Inc.	$5.96	-9.71×	1.89×	3.2×	-33.23×	-81.9%	51.8%	-20.0%	-33.0%	-19.5%	-10.3%	-1.4%	0.07×	3.86×	-85.2×	5.04×	0.0%	4	4.15	2	C+
LABStandard BioTools Inc.	$0.65	-6.4×	1.15×	5.72×	-4.68×	-325.1%	49.9%	-109.3%	-87.8%	-17.7%	-12.2%	-16.9%	0.07×	1.02×	-3,588.65×	4.19×	0.0%	3	-0.44	2	C+
OFIXOrthofix Medical Inc.	$6.61	-6.65×	1.34×	0.74×	75.69×	-1046.3%	67.1%	-8.3%	-11.2%	-20.5%	-10.0%	-0.2%	0.51×	14.82×	-3.92×	2.45×	0.0%	5	1.04	2	C
SIBNSI-BONE, Inc.	$24.91	-44.82×	4.83×	4.27×	-74.9×	97.1%	79.6%	-11.1%	-9.4%	-10.7%	-10.4%	-1.1%	0.01×	3.77×	-4.23×	8.55×	0.0%	4	6.62	2	B-
Peer median	—	-9.71×	1.89×	3.2×	-4.68×	-325.1%	67.1%	-11.1%	-11.2%	-17.7%	-10.3%	-1.1%	0.07×	3.77×	-4.23×	4.19×	0.0%	4	1.04	2	—